CAGA_STRGL
ID CAGA_STRGL Reviewed; 143 AA.
AC Q06110;
DT 01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT 01-FEB-1995, sequence version 1.
DT 25-MAY-2022, entry version 83.
DE RecName: Full=Antitumor antibiotic C-1027 apoprotein;
DE AltName: Full=C-1027-AG;
DE Flags: Precursor;
GN Name=cagA;
OS Streptomyces globisporus.
OC Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae;
OC Streptomyces.
OX NCBI_TaxID=1908;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=C-1027;
RX PubMed=1369059; DOI=10.1271/bbb.56.1592;
RA Sakata N., Ikeno S., Hori M., Hamada M., Otani T.;
RT "Cloning and nucleotide sequencing of the antitumor antibiotic C-1027
RT apoprotein gene.";
RL Biosci. Biotechnol. Biochem. 56:1592-1595(1992).
RN [2]
RP PROTEIN SEQUENCE OF 34-143.
RX PubMed=1368692; DOI=10.1271/bbb1961.55.407;
RA Otani T., Yasuhara T., Minami Y., Shimazu T., Zhang R., Xie M.Y.;
RT "Purification and primary structure of C-1027-AG, a selective antagonist of
RT antitumor antibiotic C-1027, from Streptomyces globisporus.";
RL Agric. Biol. Chem. 55:407-417(1991).
RN [3]
RP CHARACTERIZATION.
RX PubMed=8504075; DOI=10.1021/bi00072a008;
RA Sugiura Y., Matsumoto T.;
RT "Some characteristics of DNA strand scission by macromolecular antitumor
RT antibiotic C-1027 containing a novel enediyne chromophore.";
RL Biochemistry 32:5548-5553(1993).
CC -!- FUNCTION: Binds non-covalently to a chromophore which is the cytotoxic
CC and mutagenic component of the antibiotic. The chromophore binds to DNA
CC as a weak intercalator and causes single- and double-strand breaks.
CC -!- SIMILARITY: Belongs to the neocarzinostatin family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; D10827; BAA01609.1; -; Genomic_DNA.
DR PIR; JC1315; YMSMCG.
DR PDB; 1HZK; NMR; -; A=34-143.
DR PDB; 1HZL; NMR; -; A=34-143.
DR PDB; 1J48; X-ray; 1.80 A; A/B=34-143.
DR PDBsum; 1HZK; -.
DR PDBsum; 1HZL; -.
DR PDBsum; 1J48; -.
DR AlphaFoldDB; Q06110; -.
DR BMRB; Q06110; -.
DR SMR; Q06110; -.
DR DrugBank; DB03933; C-1027 Aromatized chromophore.
DR EvolutionaryTrace; Q06110; -.
DR GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
DR InterPro; IPR027273; Neocarzinostatin-like.
DR InterPro; IPR002186; Neocarzinostatin_fam.
DR Pfam; PF00960; Neocarzinostat; 1.
DR PRINTS; PR01885; MACROMOMYCIN.
DR SUPFAM; SSF49319; SSF49319; 1.
PE 1: Evidence at protein level;
KW 3D-structure; Antibiotic; Antimicrobial; Direct protein sequencing;
KW Disulfide bond; DNA-binding; Signal.
FT SIGNAL 1..33
FT /evidence="ECO:0000269|PubMed:1368692"
FT CHAIN 34..143
FT /note="Antitumor antibiotic C-1027 apoprotein"
FT /id="PRO_0000019459"
FT DISULFID 69..78
FT DISULFID 119..124
FT STRAND 36..40
FT /evidence="ECO:0007829|PDB:1J48"
FT STRAND 43..45
FT /evidence="ECO:0007829|PDB:1HZL"
FT STRAND 50..58
FT /evidence="ECO:0007829|PDB:1J48"
FT STRAND 63..72
FT /evidence="ECO:0007829|PDB:1J48"
FT STRAND 75..78
FT /evidence="ECO:0007829|PDB:1J48"
FT TURN 80..82
FT /evidence="ECO:0007829|PDB:1J48"
FT STRAND 84..87
FT /evidence="ECO:0007829|PDB:1J48"
FT STRAND 94..99
FT /evidence="ECO:0007829|PDB:1J48"
FT STRAND 102..107
FT /evidence="ECO:0007829|PDB:1J48"
FT STRAND 109..111
FT /evidence="ECO:0007829|PDB:1HZK"
FT STRAND 113..118
FT /evidence="ECO:0007829|PDB:1J48"
FT TURN 119..121
FT /evidence="ECO:0007829|PDB:1J48"
FT STRAND 125..130
FT /evidence="ECO:0007829|PDB:1J48"
FT STRAND 133..139
FT /evidence="ECO:0007829|PDB:1J48"
SQ SEQUENCE 143 AA; 13873 MW; 8CA3E57FA5DA842A CRC64;
MSLRHMSRRA SRFGVVAVAS IGLAAAAQSV AFAAPAFSVS PASGLSDGQS VSVSVSGAAA
GETYYIAQCA PVGGQDACNP ATATSFTTDA SGAASFSFVV RKSYTGSTPE GTPVGSVDCA
TAACNLGAGN SGLDLGHVAL TFG